Global X Genomics & Biotechnology ETF (GNOM)Health | Exchange Traded Fund | NasdaqGM
55.76 USD
+0.15
(0.279%)
⇧
(July 14, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 2:44 a.m. EDT
The immediate outlook is defensive. While the ETF has rallied recently, snapping off its multi-year lows, the underlying trend remains deeply broken. The price has lost nearly 40% over the last six years, with four consecutive years of negative returns ending just last year. This structural decline suggests the market continues to discount the sector's fundamentals heavily. The options data confirms this pessimism, with traders buying insurance rather than betting on a reversal. The dividend yield is negligible and unreliable, offering no cushion against further erosion. For a short-term swing trade, the recent bounce offers some relief, but the lack of momentum and overwhelming put activity suggest caution is warranted until the multi-year downtrend shows definitive signs of exhaustion. |
| Model | MAE |
|---|---|
| MSTL_126 ✓ | 0.054177 |
| MSTL_90_126 | 0.063948 |
| MSTL | 0.070799 |
| AutoETS | 0.070886 |
| AutoARIMA | 0.073558 |
| MSTL_90 | 0.074134 |
| AutoTheta | 0.078462 |
Forecast horizon: 60 days | Selected: MSTL_126
| Forecast Reliability | |
|---|---|
| Score | 36% |
| H-stat | 41.32 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.007 |
| Excess Kurtosis | -0.22 |
As of July 11, 2026, 2:44 a.m. EDT: Speculators are overwhelmingly positioning for downside protection. Put open interest dominates across all expirations, with significant concentration in strikes well below the current price (e.g., $40-$46 range). Call activity is sparse and mostly limited to deep in-the-money positions, suggesting a lack of bullish conviction. Implied volatility is elevated for near-term puts relative to calls, indicating a fear premium.
| Last Yield | 1yr Yield | 3yr Avg | 5yr Avg |
|---|---|---|---|
| 0.10% | 1.40% | 0.50% | 0.31% |
| Date | Dividend | Yield % |
|---|---|---|
| 2026-06-29 | 0.058 | 0.101541 |
| 2025-12-30 | 0.591 | 1.295768 |
| 2025-06-27 | 0.032 | 0.095238 |
| 2021-12-30 | 0.028 | 0.035035 |
| 2020-12-30 | 0.128 | 0.131959 |
| Attribute | Value |
|---|---|
| All Time High | 113.8 |
| All Time Low | 11.49 |
| Ask | 56.23 |
| Ask Size | 5 |
| Average Daily Volume10 Day | 54,100 |
| Average Daily Volume3 Month | 21,970 |
| Average Volume | 21,970 |
| Average Volume10Days | 54,100 |
| Beta3 Year | 1.6 |
| Bid | 55.38 |
| Bid Size | 5 |
| Category | Health |
| Crypto Tradeable | 0 |
| Currency | USD |
| Custom Price Alert Confidence | HIGH |
| Day High | 56.02 |
| Day Low | 55.41 |
| Dividend Yield | 1.15 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 50.1481 |
| Fifty Day Average Change | 5.6167984 |
| Fifty Day Average Change Percent | 0.112004206 |
| Fifty Two Week Change Percent | 62.41238 |
| Fifty Two Week High | 59.48 |
| Fifty Two Week High Change | -3.7150993 |
| Fifty Two Week High Change Percent | -0.06245964 |
| Fifty Two Week Low | 34.04 |
| Fifty Two Week Low Change | 21.7249 |
| Fifty Two Week Low Change Percent | 0.6382168 |
| Fifty Two Week Range | 34.04 - 59.48 |
| First Trade Date Milliseconds | 1,554,903,000,000 |
| Five Year Average Return | -0.0904584 |
| Full Exchange Name | NasdaqGM |
| Fund Family | Global X Funds |
| Fund Inception Date | 1,554,422,400 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Has Pre Post Market Data | 1 |
| Language | en-US |
| Legal Type | Exchange Traded Fund |
| Long Business Summary | The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified. |
| Long Name | Global X Genomics & Biotechnology ETF |
| Market | us_market |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_605753422 |
| Nav Price | 55.83 |
| Net Assets | 76,762,632.0 |
| Net Expense Ratio | 0.5 |
| Open | 55.95 |
| Phone | +1 8884938631 |
| Previous Close | 55.61 |
| Price Hint | 2 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | ETF |
| Region | US |
| Regular Market Change | 0.1548996 |
| Regular Market Change Percent | 0.27854627 |
| Regular Market Day High | 56.02 |
| Regular Market Day Low | 55.41 |
| Regular Market Day Range | 55.41 - 56.02 |
| Regular Market Open | 55.95 |
| Regular Market Previous Close | 55.61 |
| Regular Market Price | 55.7649 |
| Regular Market Time | 1,784,059,200 |
| Regular Market Volume | 41,174 |
| Short Name | Global X Genomics & Biotechnolo |
| Source Interval | 15 |
| Symbol | GNOM |
| Three Year Average Return | 0.048955698 |
| Total Assets | 76,762,632 |
| Tradeable | 0 |
| Trailing Peg Ratio | None |
| Trailing Three Month Nav Returns | 29.66318 |
| Trailing Three Month Returns | 29.66318 |
| Triggerable | 1 |
| Two Hundred Day Average | 46.3328 |
| Two Hundred Day Average Change | 9.432098 |
| Two Hundred Day Average Change Percent | 0.20357281 |
| Type Disp | ETF |
| Volume | 41,174 |
| Yield | 0.0115 |
| Ytd Return | 24.56662 |